[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

LT3593B - Drugs and process for preparing thereof - Google Patents

Drugs and process for preparing thereof Download PDF

Info

Publication number
LT3593B
LT3593B LTIP919A LTIP919A LT3593B LT 3593 B LT3593 B LT 3593B LT IP919 A LTIP919 A LT IP919A LT IP919 A LTIP919 A LT IP919A LT 3593 B LT3593 B LT 3593B
Authority
LT
Lithuania
Prior art keywords
flupirtine
excipients
process according
treatment
acid
Prior art date
Application number
LTIP919A
Other languages
English (en)
Lithuanian (lt)
Inventor
Michael Dr Lobisch
Ralph Dr Venhaus
Bernd Dr Nickel
Istvan Prof Szelenyi
Juergen Prof Engel
Peter Dr Emig
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of LTIP919A publication Critical patent/LTIP919A/xx
Publication of LT3593B publication Critical patent/LT3593B/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrrole Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Golf Clubs (AREA)
  • Details Of Television Scanning (AREA)
  • Paints Or Removers (AREA)
  • Medicines Containing Plant Substances (AREA)
LTIP919A 1990-07-14 1993-09-03 Drugs and process for preparing thereof LT3593B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4022442 1990-07-14
IN421CA1991 IN172468B (lv) 1990-07-14 1991-06-04

Publications (2)

Publication Number Publication Date
LTIP919A LTIP919A (en) 1995-03-27
LT3593B true LT3593B (en) 1995-12-27

Family

ID=25895002

Family Applications (1)

Application Number Title Priority Date Filing Date
LTIP919A LT3593B (en) 1990-07-14 1993-09-03 Drugs and process for preparing thereof

Country Status (30)

Country Link
US (2) US5162346A (lv)
EP (2) EP0659410B1 (lv)
KR (1) KR0182811B1 (lv)
CN (1) CN1070700C (lv)
AT (2) ATE133564T1 (lv)
AU (1) AU634073B2 (lv)
CA (1) CA2046943C (lv)
CZ (1) CZ280879B6 (lv)
DE (3) DE4122166A1 (lv)
DK (2) DK0467164T3 (lv)
EG (1) EG19814A (lv)
ES (2) ES2082887T3 (lv)
GR (1) GR3019179T3 (lv)
HR (1) HRP920667B1 (lv)
HU (1) HU206973B (lv)
IE (1) IE74688B1 (lv)
IL (1) IL98810A (lv)
IN (1) IN172468B (lv)
LT (1) LT3593B (lv)
LV (1) LV10048B (lv)
MC (1) MC2272A1 (lv)
MX (1) MX9100160A (lv)
NO (1) NO912758L (lv)
NZ (1) NZ238940A (lv)
PT (1) PT98291B (lv)
RO (1) RO108220B1 (lv)
RU (1) RU2070408C1 (lv)
SI (1) SI9111227B (lv)
SK (1) SK279567B6 (lv)
ZA (1) ZA915466B (lv)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0560092T3 (da) * 1992-03-11 1998-08-10 Asta Medica Ag Tabletter, granulater og pellets med højt indholdaf aktivstoffer til højkoncentrerede, faste administreringsformer
DE4319649A1 (de) * 1993-03-18 1994-09-22 Asta Medica Ag Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe
DE4327516A1 (de) * 1993-08-17 1995-02-23 Asta Medica Ag Primäre und sekundäre neuroprotektive Wirkung bei neurodegenerativen Erkrankungen von Flupirtin
GB9426079D0 (en) * 1994-12-23 1995-02-22 Orion Yhtymae Oy A gelatine capsule
DE19541405A1 (de) * 1995-11-07 1997-05-15 Asta Medica Ag Verwendung von Flupirtin zur Prophylaxe und Therapie von Erkrankungen, die mit einer Beeinträchtigung des hämatopoetischen Zellsystems einhergehen
US6284794B1 (en) 1996-11-05 2001-09-04 Head Explorer Aps Method for treating tension-type headache with inhibitors of nitric oxide and nitric oxide synthase
US6610324B2 (en) * 1999-04-07 2003-08-26 The Mclean Hospital Corporation Flupirtine in the treatment of fibromyalgia and related conditions
RU2002105502A (ru) * 1999-08-03 2004-03-20 АВД.фарма ГмбХ унд Ко. КГ (DE) Применение флупиртина для облегчения болей, вызванных дегенеративными заболеваниями суставов у собак и кошек
US6821995B1 (en) 1999-12-01 2004-11-23 Duke University Method of treating batten disease
US20040122090A1 (en) * 2001-12-07 2004-06-24 Lipton Stuart A. Methods for treating neuropsychiatric disorders with nmda receptor antagonists
RU2213565C1 (ru) * 2002-06-24 2003-10-10 Общество с ограниченной ответственностью "Паркинфарм" Способ лечебного воздействия на организм пациента при лечении болезни паркинсона
DE10255415A1 (de) * 2002-11-28 2004-06-09 Bayer Healthcare Ag Dermale Applikation von Flupirtin
DE10327674A1 (de) * 2003-06-20 2005-01-05 Awd.Pharma Gmbh & Co. Kg Injizierbare Darreichungsform von Flupirtin
US20050089559A1 (en) 2003-10-23 2005-04-28 Istvan Szelenyi Combinations of potassium channel openers and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
US20050196461A1 (en) * 2004-01-14 2005-09-08 Udell Ronald G. Ceramide formulations suitable for oral administration
KR20060124731A (ko) * 2004-01-29 2006-12-05 뉴로몰레큘라 파마슈티칼스, 인코포레이티드 중추신경계-관련 질환 치료용 ｎｍｄａ 수용체 길항제 및ｍａｏ-억제제 또는 ｇａｄｐｈ-억제제의 배합물
US20050220862A1 (en) 2004-03-31 2005-10-06 Bernstein Joel E Compositions with reduced hepatotoxicity
US7619007B2 (en) * 2004-11-23 2009-11-17 Adamas Pharmaceuticals, Inc. Method and composition for administering an NMDA receptor antagonist to a subject
EP1688141A1 (en) * 2005-01-31 2006-08-09 elbion AG The use of flupirtine for the treatment of overactive bladder and associated diseases, and for the treatment of irritable bowel syndrome
RU2007140348A (ru) 2005-04-06 2009-05-20 Адамас Фармасьютикалс, Инк. (Us) Способы и композиции для лечения заболеваний цнс
EP2012769A1 (en) * 2006-05-02 2009-01-14 Rundfeldt, Chris Potassium channel activators for the prevention and treatment of dystonia and dystonia-like symptoms
US7960436B2 (en) * 2006-06-05 2011-06-14 Valeant Pharmaceuticals International Substituted arylamino-1,2,3,4-tetrahydro naphthalenes and-2,3-dihydro-1H-indenes as potassium channel modulators
DK2061465T3 (da) * 2006-08-23 2013-07-08 Valeant Pharmaceuticals Int Derivater af 4-(N-azacycloalkyl)anilider som kaliumkanalmodulatorer
US8993593B2 (en) * 2006-08-23 2015-03-31 Valeant Pharmaceuticals International N-(4-(6-fluoro-3,4-dihydroisoquinolin-2(1H)-yl)-2,6-dimethylphenyl)-3,3-dimethylbutanamide as potassium channel modulators
US8722929B2 (en) * 2006-10-10 2014-05-13 Valeant Pharmaceuticals International N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators
EA200900749A1 (ru) * 2006-11-28 2009-12-30 Валеант Фармасьютикалс Интернэшнл 1,4-диаминобициклические аналоги ретигабина как модуляторы калиевых каналов
US20080279930A1 (en) * 2007-05-07 2008-11-13 Bernd Terhaag Controlled-Release Flupirtine Compositions, Compacts, Kits and Methods of Making and Use Thereof
US8367684B2 (en) * 2007-06-13 2013-02-05 Valeant Pharmaceuticals International Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
US8563566B2 (en) * 2007-08-01 2013-10-22 Valeant Pharmaceuticals International Naphthyridine derivatives as potassium channel modulators
EP2185149A1 (en) * 2007-08-01 2010-05-19 H. Lundbeck A/S Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted
US7786146B2 (en) * 2007-08-13 2010-08-31 Valeant Pharmaceuticals International Derivatives of 5-amino-4,6-disubstituted indole and 5-amino-4,6-disubstituted indoline as potassium channel modulators
ES2347119B2 (es) * 2009-04-22 2011-04-28 Universidad De Santiago De Compostela Nanocapsulas de poliarginina.
DE102010030053A1 (de) 2010-06-14 2011-12-15 Awd.Pharma Gmbh & Co.Kg Injizierbare Darreichungsform von Flupirtin
JP6251667B2 (ja) * 2014-06-03 2017-12-20 アサヒカルピスウェルネス株式会社 錠剤型即放性製剤及びその製造方法
DE102017007385A1 (de) 2017-08-02 2019-02-07 Christoph Hoock Maleatfreie feste Arzneimittelformen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795858C2 (de) 1968-07-19 1979-01-11 Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler, 6000 Frankfurt Benzylaminopyridine
DE3133519A1 (de) 1980-09-13 1982-06-09 Degussa Ag, 6000 Frankfurt "2-amino-3-carbethoxyamino-6-(p-fluor-benzylamino)-pyridin-maleat"
DE3665538D1 (en) * 1985-01-23 1989-10-19 Asta Pharma Ag Synergistic combination of flupirtin and non-steroidal anti-phlogistics
EP0193056B1 (de) * 1985-02-23 1989-06-07 ASTA Pharma Aktiengesellschaft Kombination von Flupirtin und anticholinergisch wirkenden Spasmolytika
DE3604575A1 (de) * 1985-02-23 1986-08-28 Degussa Ag, 6000 Frankfurt Kombination von flupirtin und anticholinergisch wirkenden spasmolytika
FI855016A (fi) * 1985-06-28 1986-12-29 Degussa Synergistisk kombination av flupirtin och 4-acetamido-fenol.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SUCHES ET AL.: "Pharmaceutische Technologie"

Also Published As

Publication number Publication date
ES2082887T3 (es) 1996-04-01
LV10048B (en) 1995-06-20
EG19814A (en) 1996-02-29
ES2164111T3 (es) 2002-02-16
HU206973B (en) 1993-03-01
AU8040391A (en) 1992-01-16
NO912758L (no) 1992-01-15
IL98810A0 (en) 1992-07-15
DK0659410T3 (da) 2001-12-27
EP0467164B1 (de) 1996-01-31
EP0659410A3 (de) 1995-10-25
IE74688B1 (en) 1997-07-30
KR0182811B1 (ko) 1999-05-01
MC2272A1 (fr) 1993-06-23
US5284861A (en) 1994-02-08
ZA915466B (en) 1992-04-29
NZ238940A (en) 1997-05-26
RO108220B1 (ro) 1994-03-31
PT98291A (pt) 1992-05-29
DK0467164T3 (da) 1996-03-04
GR3019179T3 (en) 1996-06-30
DE4122166A1 (de) 1992-01-16
ATE133564T1 (de) 1996-02-15
CA2046943A1 (en) 1992-01-15
RU2070408C1 (ru) 1996-12-20
MX9100160A (es) 1992-02-28
EP0467164A3 (en) 1992-04-15
CN1058716A (zh) 1992-02-19
HRP920667A2 (en) 1996-10-31
EP0467164A2 (de) 1992-01-22
CA2046943C (en) 1996-03-12
NO912758D0 (no) 1991-07-12
SI9111227A (en) 1995-06-30
IL98810A (en) 1996-01-19
SI9111227B (sl) 2000-12-31
HU912359D0 (en) 1991-12-30
LV10048A (lv) 1994-05-10
AU634073B2 (en) 1993-02-11
CS210191A3 (en) 1992-02-19
PT98291B (pt) 1999-01-29
LTIP919A (en) 1995-03-27
HRP920667B1 (en) 1998-06-30
EP0659410B1 (de) 2001-10-17
SK279567B6 (sk) 1999-01-11
DE59107331D1 (de) 1996-03-14
EP0659410A2 (de) 1995-06-28
IE912451A1 (en) 1992-01-15
DE59109222D1 (de) 2001-11-22
KR920002147A (ko) 1992-02-28
ATE206919T1 (de) 2001-11-15
IN172468B (lv) 1993-08-14
HUT59313A (en) 1992-05-28
CZ280879B6 (cs) 1996-04-17
US5162346A (en) 1992-11-10
CN1070700C (zh) 2001-09-12

Similar Documents

Publication Publication Date Title
LT3593B (en) Drugs and process for preparing thereof
EP0098743B1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
JP4209467B2 (ja) 経口投与用製剤組成物
JP2991733B2 (ja) 乾癬疾患を抑制するための薬剤及びその製法
PT904064E (pt) Composicoes farmaceuticas orais contendo hormonas sexuais
EP0672422A1 (en) Antiinflammatory and analgesic transdermal gel
JPS6144809A (ja) ４−ビフエニリル酢酸系化合物含有脂肪乳剤
KR20010102297A (ko) 양자 펌프 억제제를 함유하는 약제학적 조성물
US4259323A (en) Potassium chloride emulsion
JPS62270521A (ja) フルルビプロフエン眼投与製剤
JPH07188027A (ja) 安定な酪酸ヒドロコルチゾン含有クリーム剤
JPS63406B2 (lv)
AU2013288231B2 (en) Pediatric oral liquid compositions containing Nepadutant
JPH0892088A (ja) 経口投与用油性組成物
JP2003521495A (ja) テルビナフィン含有医薬組成物
TW202228668A (zh) 外用醫藥組成物
WO2010102991A2 (en) Riluzole liquid emulsions
JP2009029711A (ja) 用時溶解型ビタミン製剤及びその製造方法
JPH06145055A (ja) 局所投与用医薬
JPH08208598A (ja) プロスタグランジン類組成物
JPH0532627A (ja) 筋肉痙攣により帰因するか又は筋肉痙攣の結果である疾病及び症候群を治療するための医薬品及びその製法
IE84029B1 (en) Use of the compound flupirtin for the preparation of a medicament against muscle bracing
JPH0570371A (ja) 動物用脂溶性ビタミン製剤
OA17358A (en) Pediatric oral liquid compositions containing nepadutant.

Legal Events

Date Code Title Description
PC9A Transfer of patents

Free format text: 20020524 * AWD.PHARMA GMBH & CO.KG,DE

MK9A Expiry of a patent

Effective date: 20130903